BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25373532)

  • 1. Interleukin-8 promotes human ovarian cancer cell migration by epithelial-mesenchymal transition induction in vitro.
    Yin J; Zeng F; Wu N; Kang K; Yang Z; Yang H
    Clin Transl Oncol; 2015 May; 17(5):365-70. PubMed ID: 25373532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [IL-8 Induces Epithelial-to-mesenchymal Transition of Ovarian Carcinoma Cells: a Preliminary Study].
    Wang SC; Fu HH; Wen JR; Zhao ZW; Nie YM; Miao YL; Wu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):420-424. PubMed ID: 30014646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-β in ovarian tumor cell lines.
    Pazos MC; Abramovich D; Bechis A; Accialini P; Parborell F; Tesone M; Irusta G
    Mol Cell Endocrinol; 2017 Jan; 440():125-137. PubMed ID: 27908834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
    Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
    Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
    Gao S; Hu J; Wu X; Liang Z
    Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal Transition.
    Hou YF; Gao SH; Wang P; Zhang HM; Liu LZ; Ye MX; Zhou GM; Zhang ZL; Li BY
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.
    Hu C; Dong T; Li R; Lu J; Wei X; Liu P
    Oncol Rep; 2016 Apr; 35(4):2027-34. PubMed ID: 26820690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8/β-catenin mediates epithelial-mesenchymal transition in ameloblastoma.
    Zhang J; Wang Y; Fan C; Xiao X; Zhang Q; Xu T; Jiang C
    Oral Dis; 2019 Nov; 25(8):1964-1971. PubMed ID: 31397928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.
    Comamala M; Pinard M; Thériault C; Matte I; Albert A; Boivin M; Beaudin J; Piché A; Rancourt C
    Br J Cancer; 2011 Mar; 104(6):989-99. PubMed ID: 21326240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF18 Enhances Migration and the Epithelial-Mesenchymal Transition in Breast Cancer by Regulating Akt/GSK3β/Β-Catenin Signaling.
    Song N; Zhong J; Hu Q; Gu T; Yang B; Zhang J; Yu J; Ma X; Chen Q; Qi J; Liu Y; Su W; Feng Z; Wang X; Wang H
    Cell Physiol Biochem; 2018; 49(3):1019-1032. PubMed ID: 30196303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    Yang Z; Ji L; Jiang G; Liu R; Liu Z; Yang Y; Ma Q; Zhao H
    Biosci Trends; 2018; 12(1):40-46. PubMed ID: 29553100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-8 promotes cell migration through regulating EMT by activating the Wnt/β-catenin pathway in ovarian cancer.
    Wen J; Zhao Z; Huang L; Wang L; Miao Y; Wu J
    J Cell Mol Med; 2020 Jan; 24(2):1588-1598. PubMed ID: 31793192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression.
    Liu R; Zheng J; Li C; Pang Y; Zheng Q; Xu X; Liu P
    Arch Gynecol Obstet; 2015 Jun; 291(6):1361-9. PubMed ID: 25424898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.
    Sun Q; Dong M; Wang Z; Wang C; Sheng D; Li Z; Huang D; Yuan C
    Oncotarget; 2016 May; 7(19):28369-83. PubMed ID: 27058760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
    Burkhalter RJ; Westfall SD; Liu Y; Stack MS
    J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells.
    Nagaharu K; Zhang X; Yoshida T; Katoh D; Hanamura N; Kozuka Y; Ogawa T; Shiraishi T; Imanaka-Yoshida K
    Am J Pathol; 2011 Feb; 178(2):754-63. PubMed ID: 21281808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.